CAI
Price:
$17.97
Market Cap:
$5.08B
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encom...[Read more]
Industry
Biotechnology
IPO Date
2025-06-18
Stock Exchange
NASDAQ
Ticker
CAI
According to Caris Life Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 6.47%. This represents a change of 673.38% compared to the average of 0.84% of the last 4 quarters.
The mean historical ROE of Caris Life Sciences, Inc. over the last ten years is -0.76%. The current 6.47% ROE has changed -952.67% with respect to the historical average. Over the past ten years (40 quarters), CAI's ROE was at its highest in in the December 2025 quarter at 14.20%. The ROE was at its lowest in in the June 2025 quarter at -15.85%.
Average
-0.76%
Median
8.52%
Minimum
-93.18%
Maximum
18.85%
Discovering the peaks and valleys of Caris Life Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 874.98%
Maximum Annual ROE = 18.85%
Minimum Annual Increase = -926.04%
Minimum Annual ROE = -93.18%
| Year | ROE | Change |
|---|---|---|
| 2025 | -93.18% | -926.04% |
| 2024 | 11.28% | -29.13% |
| 2023 | 15.92% | -15.55% |
| 2022 | 18.85% | 377.28% |
| 2020 | 3.95% | -11.72% |
| 2019 | 4.47% | -60.09% |
| 2018 | 11.21% | -12.29% |
| 2017 | 12.78% | 874.98% |
| 2016 | 1.31% | -77.52% |
| 2015 | 5.83% | -57.24% |
The current ROE of Caris Life Sciences, Inc. (CAI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.00%
5-year avg
-8.64%
10-year avg
-0.76%
Caris Life Sciences, Inc.’s ROE is less than Jazz Pharmaceuticals plc (0.71%), greater than Atrium Therapeutics, Inc. (-29.67%), greater than Moderna, Inc. (-36.73%), less than Cytokinetics, Incorporated (139.66%), greater than Madrigal Pharmaceuticals, Inc. (-50.15%), less than Halozyme Therapeutics, Inc. (126.27%), greater than Merus N.V. (-50.79%), greater than Abivax S.A. (-165.19%), less than Corcept Therapeutics Incorporated (7.50%), greater than Rhythm Pharmaceuticals, Inc. (-203.25%),
| Company | ROE | Market cap |
|---|---|---|
| 0.71% | $14.48B | |
| -29.67% | $211.60M | |
| -36.73% | $19.80B | |
| 139.66% | $8.73B | |
| -50.15% | $11.08B | |
| 126.27% | $8.24B | |
| -50.79% | $6.83B | |
| -165.19% | $6.33B | |
| 7.50% | $8.90B | |
| -203.25% | $6.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caris Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Caris Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Caris Life Sciences, Inc.'s ROE?
How is the ROE calculated for Caris Life Sciences, Inc. (CAI)?
What is the highest ROE for Caris Life Sciences, Inc. (CAI)?
What is the 3-year average ROE for Caris Life Sciences, Inc. (CAI)?
What is the 5-year average ROE for Caris Life Sciences, Inc. (CAI)?
How does the current ROE for Caris Life Sciences, Inc. (CAI) compare to its historical average?